![](https://investorshub.advfn.com/uicon/44942.png?cb=1559860265)
Wednesday, March 25, 2020 7:59:47 AM
"Has the coronavirus had any impact on your business in a good way or bad way?" asked Jolly to start the interview. "It has certainly had an impact. The most rewarding part of the impact, other than gaining business, is the awareness that it has caused both from the public and in particular health care facilities how important it is to be proactive against these events," said Grieco. "We're in this to make a profit, but the first priority of this company has always been the care and safety of people."
Jolly then asked about the Company's flagship product. Grieco explained that the Company has developed a unique type of disinfectant system based on hypochlorous acid. "The core technology, which is hypochlorous acid, has been around for many years, but it's had what the market has perceived as drawbacks - not because of its efficacy, but because it's not a product that lends itself to storage long-term," explained Grieco. He emphasized that their disinfecting system has demonstrated its ability to destroy various bacteria and viruses, without the noxious and other adverse side effects found with conventional chlorine solutions.
"The product is made on-site so that you don't have a concern that the solutions you are using are somehow impacted as far as efficacy," said Grieco about the Company's disinfecting system. "The other thing we've done is created a total system, whereby it is a systems of protocols," said Grieco, adding that their system has been shown to improve the efficiency of health care facilities in combating infectious diseases.
The conversation then turned to the Company's operations in the UK. "We entered upon a 60 day test with Leeds Hospital and two universities, which are expected to be completed sometime by the end of this month or certainly by the first week of April," said Grieco. "PCT UK, which is a company that we formed over there in conjunction with our partners, has signed an agreement with the British Health Care System that once the tests are finished and everything is proven to be accurate they will start installing them throughout their whole system," he explained. "That is a huge future market for us."
Recent PCTL News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 02:05:09 PM
- Form 15-12G/A - Securities registration termination [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 07/18/2023 07:06:52 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/13/2023 04:32:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM